Crespo J, Lozano J L, Carte B, de las Heras B, de la Cruz F, Pons-Romero F
Gastroenterology and Hepatology Unit, University Hospital Marqués de Valdecilla, Faculty of Medicine, Cantabria, Spain.
Eur J Clin Microbiol Infect Dis. 1997 Jun;16(6):445-51. doi: 10.1007/BF02471908.
The aim of this study was to assess the implications of dual infection with hepatitis B virus (HBV) and hepatitis C virus (HCV). The HBV and HCV status in 100 patients with chronic hepatitis was analysed. HBV DNA was studied using liquid hybridization and the polymerase chain reaction (PCR). HCV viremia was measured using qualitative and quantitative PCR. The HCV genotype was determined by PCR. Patients were divided into three groups according to their HCV-RNA and HBsAg status: group I consisted of 40 patients with chronic hepatitis caused by HBV; group II, 40 patients with chronic hepatitis caused by HCV; and group III, 20 patients infected with both viruses. The HBV-DNA level was higher in group I than in group III (66.4 vs. 11.5 pg/ml; p < 0.05). Quantification of HCV viremia revealed mean values of 36.9 copies x 10(5)/ml in group II and 5.5 copies/ml x 10(5) in group III (p < 0.05). The mean aminotransferase level and histological activity were higher in group III. HCV genotype lb was the predominant type. The data suggest that there is reciprocal inhibition of viral replication in patients with dual HBV and HCV infection. Liver disease appears to be more severe in patients with chronic hepatitis B and C.
本研究的目的是评估乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)双重感染的影响。分析了100例慢性肝炎患者的HBV和HCV状况。使用液相杂交和聚合酶链反应(PCR)研究HBV DNA。使用定性和定量PCR测量HCV病毒血症。通过PCR确定HCV基因型。根据患者的HCV-RNA和HBsAg状况将患者分为三组:第一组由40例由HBV引起的慢性肝炎患者组成;第二组,40例由HCV引起的慢性肝炎患者;第三组,20例同时感染两种病毒的患者。第一组的HBV-DNA水平高于第三组(66.4对11.5 pg/ml;p<0.05)。HCV病毒血症定量显示,第二组的平均值为36.9拷贝×10(5)/ml,第三组为5.5拷贝/ml×10(5)(p<0.05)。第三组的平均转氨酶水平和组织学活性更高些。HCV基因型1b是主要类型。数据表明,HBV和HCV双重感染患者存在病毒复制的相互抑制。慢性乙型和丙型肝炎患者的肝病似乎更严重。